Search Within

Maria Eugenia Arcila

Formats
  1. Meeting Abstract (391)
  2. Journal Article (247)
  3. Research Letter (12)
  4. Book Section (8)
  5. Review (7)
  6. Editorial (2)
  7. Guidelines (2)
  8. Book Whole (1)
Groups
  1. Department of Pathology and Laboratory Medicine (670)
  2. Department of Medicine (458)
  3. GSK Faculty (456)
  4. Human Oncology and Pathogenesis Program (427)
  5. Tow Center for Developmental Oncology (TCDO) (346)
  6. Solid Tumor Oncology Division (317)

More Groups

People
  1. Marc Ladanyi (301)
  2. Michael Berger (163)
  3. Ahmet Zehir (126)
  4. Mark Kris (123)
  5. Khedoudja Nafa (108)
  6. Ryma Benayed (99)

More People

Years
  1. 2025 (11)
  2. 2024 (29)
  3. 2023 (43)
  4. 2022 (32)
  5. 2021 (37)
  6. 2020 (68)

More Years

Publications
  1. Journal of Molecular Diagnostics (93)
  2. Journal of Clinical Oncology (80)
  3. Laboratory Investigation (74)
  4. Modern Pathology (69)
  5. Blood (55)
  6. Clinical Cancer Research (36)

More Publications

Publishers
  1. Elsevier Science, Inc. (98)
  2. Nature Publishing Group (97)
  3. American Society of Clinical Oncology (96)
  4. Nature Research (69)
  5. American Association for Cancer Research (61)
  6. American Society of Hematology (61)

More Publishers

Results (670)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • EGFR exon 20 mutations: Molecular spectrum, incidence and clinicopathologic characteristics
    Meeting Abstract

    Liu, Y. C.; Nafa, K.; Chaft, J. E.; Rekhtman, N.; Reva, B.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.; Arcila, M. E.
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • EGFR exon 20 mutations: Molecular spectrum, incidence and clinicopathologic characteristics
    Meeting Abstract

    Liu, Y. C.; Nafa, K.; Chaft, J. E.; Rekhtman, N.; Reva, B.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.; Arcila, M. E.
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • Assessment of BRAF V600E mutation status by immunohistochemistry in lung and ovarian carcinomas
    Meeting Abstract

    Kabiawu Ajise, O. E.; Feldstein, J. T.; Soslow, R.; Levine, D.; Ladanyi, M.; Arcila, M. E.
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • Assessment of BRAF V600E mutation status by immunohistochemistry in lung and ovarian carcinomas
    Meeting Abstract

    Kabiawu Ajise, O. E.; Feldstein, J. T.; Soslow, R.; Levine, D.; Ladanyi, M.; Arcila, M. E.
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • Follicular dendritic cell sarcoma: An underrecognized disease entity with highly heterogeneous clinical, pathologic, and histogenetic characteristics
    Meeting Abstract

    Bohn, O. L.; Maragulia, J.; Lin, O.; Zelenetz, A. D.; Teruya-Feldstein, J.; Arcila, M. E.
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • Follicular dendritic cell sarcoma: An underrecognized disease entity with highly heterogeneous clinical, pathologic, and histogenetic characteristics
    Meeting Abstract

    Bohn, O. L.; Maragulia, J.; Lin, O.; Zelenetz, A. D.; Teruya-Feldstein, J.; Arcila, M. E.
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • Evaluation of ER, PR and Her2 in breast carcinoma metastatic to bone: A comparison of results between FNA cell blocks and surgical biopsies
    Meeting Abstract

    Aggarwal, G.; Magda, J.; Arcila, M. E.; Lin, O.; Edelweiss, M.
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • Evaluation of ER, PR and Her2 in breast carcinoma metastatic to bone: A comparison of results between FNA cell blocks and surgical biopsies
    Meeting Abstract

    Aggarwal, G.; Magda, J.; Arcila, M. E.; Lin, O.; Edelweiss, M.
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • EGFR exon 20 insertion mutations in lung adenocarcinomas: Prevalence, molecular heterogeneity, and clinicopathologic characteristics
    Journal Article

    Arcila, M. E.; Nafa, K.; Chaft, J. E.; Rekhtman, N.; Lau, C.; Reva, B. A.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.
    Molecular Cancer Therapeutics (2013)

    Fulltext@MSK | Save
  • KIF5B-RET: Discovery of a novel fusion oncogene in lung adenocarcinomas by a systematic screen for tyrosine kinase fusions and identification of patients for a RET targeted therapy trial
    Meeting Abstract

    Suehara, Y.; Arcila, M. E.; Drilon, A. E. D.; Ito, T.; Wang, L.; Hasanovic, A.; Khanin, R.; Rizvi, N. A.; Ladanyi, M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save